Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 41-45 of 45 (Search time: 0.004 seconds).
Item hits:
Issue DateTitleAuthor(s)
30-Jan-2024In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and NeuroblastomaOrton, S; Karkia, R; Mustafov, D; Gharanei, S; Braoudaki, M; Filipe, A; Panfilov, S; Saravi, S; Khan, N; Kyrou, I; Karteris, E; Chatterjee, J; Randeva, HS
27-Dec-2022Elevated Circulating Lactate Levels and Widespread Expression of Its Cognate Receptor, Hydroxycarboxylic Acid Receptor 1 (HCAR1), in Ovarian CancerKerslake, R; Panfilov, S; Mustafa, N; Hall, M; Kyrou, I; Randeva, H; Karteris, E; Godfrey, R
25-Mar-2023Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this SettingAlizzi, Z; Roxburgh, P; Cartwright, D; McLaren, A; Park, S; Jones, R; Greening, S; Hudson, E; Green, C; Gray, S; Khalique, S; Karteris, E; Hall, M
27-Apr-2024Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro ModelMorea, A; Saravi, S; Sisu, C; Hall, M; Tosi, S; Karteris, E; Storlazzi, CT
19-Mar-2024SV2B/miR-34a/miR-128 axis as prognostic biomarker in glioblastoma multiformeMustafov, D; Siddiqui, SS; Klena, L; Karteris, E; Braoudaki, M